Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxia He

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Cancer Research and Clinical Oncology|July 9, 2022
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosisYanxia He, Yan Gao, Liqin Ping, et al.
Biomaterials|May 22, 2015
Blood-brain barrier-permeable fluorone-labeled dieckols acting as neuronal ER stress signaling inhibitorsJong Hwan Kwak, Zhigang Yang, Byungkwon Yoon, et al.
Chemical Communications (Cambridge, England)|July 19, 2014
Synthesis of rhodamine-labelled dieckol: its unique intracellular localization and potent anti-inflammatory activityJong Hwan Kwak, Yanxia He, Byungkwon Yoon, et al.
Pediatric Pulmonology|October 22, 2010
Hospitalized children with 2009 influenza a (H1N1) infection in Shenzhen, China, November-December 2009Yuejie Zheng, Yanxia He, Jikui Deng, et al.
Pediatric Investigation|August 28, 2020
Pandemic 2009 influenza A (H1N1)-associated deaths among children in China: A retrospective analysisZhiwei Lu, Yuejie Zheng, Yanxia He, et al.
Plos One|October 1, 2014
Serum amyloid A and clusterin as potential predictive biomarkers for severe hand, foot and mouth disease by 2D-DIGE proteomics analysisJianjun Liu, Peiwu Huang, Yaqing He, et al.
Signal Transduction and Targeted Therapy|May 16, 2024
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II studyYan Gao, Haixia He, Xueping Li, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Cancer Research and Clinical Oncology|July 9, 2022
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosisYanxia He, Yan Gao, Liqin Ping, et al.
Biomaterials|May 22, 2015
Blood-brain barrier-permeable fluorone-labeled dieckols acting as neuronal ER stress signaling inhibitorsJong Hwan Kwak, Zhigang Yang, Byungkwon Yoon, et al.
Chemical Communications (Cambridge, England)|July 19, 2014
Synthesis of rhodamine-labelled dieckol: its unique intracellular localization and potent anti-inflammatory activityJong Hwan Kwak, Yanxia He, Byungkwon Yoon, et al.
Pediatric Pulmonology|October 22, 2010
Hospitalized children with 2009 influenza a (H1N1) infection in Shenzhen, China, November-December 2009Yuejie Zheng, Yanxia He, Jikui Deng, et al.
Pediatric Investigation|August 28, 2020
Pandemic 2009 influenza A (H1N1)-associated deaths among children in China: A retrospective analysisZhiwei Lu, Yuejie Zheng, Yanxia He, et al.
Plos One|October 1, 2014
Serum amyloid A and clusterin as potential predictive biomarkers for severe hand, foot and mouth disease by 2D-DIGE proteomics analysisJianjun Liu, Peiwu Huang, Yaqing He, et al.
Signal Transduction and Targeted Therapy|May 16, 2024
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II studyYan Gao, Haixia He, Xueping Li, et al.
Pageof 6